| Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells S Aggarwal, S John, L Sapra, SC Sharma, SN Das Cancer chemotherapy and pharmacology 83 (3), 451-461, 2019 | 56 | 2019 |
| Bioluminescence for in vivo detection of cell-type-specific inflammation in a mouse model of uveitis S John, K Rolnick, L Wilson, S Wong, RN Van Gelder, KL Pepple Scientific Reports 10 (1), 1-12, 2020 | 10 | 2020 |
| Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis. S John, OH Bell, L Wilson, DA Copland, KL Pepple Journal of visualized experiments: JoVE, 2021 | 2 | 2021 |
| Abstract A29: Targeted disruption of PI3K/Akt/mTOR signaling pathway induces cell cycle arrest, apoptosis, autophagy, and inhibits inflammation, invasion, and angiogenesis of … S Aggarwal, S John, SN Das, SC Sharma Molecular Cancer Research 18 (10 Supplement), A29-A29, 2020 | | 2020 |
| Characterization of intraocular inflammation following intravitreal AAV injection in a mouse model G Tummala, A Crain, S John, J Rowlan, M Neitz, R Van Gelder, K Pepple Investigative Ophthalmology & Visual Science 61 (7), 443-443, 2020 | | 2020 |
| Abstract A60: Targeted disruption of PI3K/Akt/mTOR signaling pathway induces cell cycle arrest, apoptosis, and autophagy, and inhibits inflammation, invasion and angiogenesis … S Aggarwal, S John, SC Sharma, SN Das Cancer Immunology Research 8 (4 Supplement), A60-A60, 2020 | | 2020 |
| Targeted disruption of PI3K/Akt/mTOR signaling pathway induces cell cycle arrest, apoptosis, and autophagy, and inhibits inflammation, invasion and angiogenesis of OSCC cells. S Aggarwal, S John, SC Sharma, SN Das CANCER IMMUNOLOGY RESEARCH 8 (4), 66-67, 2020 | | 2020 |
